Expression of serum Hcy, GAL3 and MCP-1 in patients with acute ischemic stroke and its clinical significance

Abstract

Objective To investigate the expression and clinical significance of serum homocysteine (Hcy), galectin-3 (GAL3) and monocyte chemotactic protein-1 (MCP-1) in patients with acute ischemic stroke (ACIS). Methods 100 patients with ACIS in our hospital from January 2016 to February 2018 were selected as the observation group, and 64 healthy persons in our hospital were selected as the control group during the same period. The levels of serum Hcy, GAL3 and MCP-1 were detected and compared between the two groups. The levels of serum Hcy, GAL3 and MCP-1 in patients with different pathological changes, different cerebral infarction areas and different prognosis in the observation group were compared. The correlation between serum Hcy, GAL3 and MCP-1 levels and ACIS cerebral infarction area and neurological deficit scale (NIHSS) was analyzed. The sensitivity, specificity and accuracy of MCP-1 in diagnosing ACIS alone and in combination. Results The levels of serum Hcy, GAL3 and MCP-1 in the observation group were higher than those in the control group (P<0.05). There were significant differences in serum Hcy, GAL3 and MCP-1 levels between the patients with different pathological degrees of disease (P<0.05). The level of the above-mentioned indicators in patients with severe injury was higher than that in patients with moderate injury. The patients with moderate injury were higher than those with mild injury (P<0.05). There were significant differences in serum Hcy, GAL3 and MCP-1 levels in patients with different cerebral infarction areas (P<0.05), and the above-mentioned index level of patients with large-area infarction was higher than that of patients with moderate-area infarction. The patients with moderate-area infarction were higher than those with small-area infarction (P<0.05). The levels of serum Hcy, GAL3 and MCP-1 in the dead patients in the observation group were higher than those in the survivors (P<0.05); correlation analysis showed that serum Hcy, GAL3, MCP-1 levels were positively correlated with ACIS cerebral infract size and NIHSS score (P<0.05); the sensitivity (91.00%) and accuracy (83.54%) of combined diagnosis of ACIS were higher than the single-index diagnosis (P<0.05). Conclusions The levels of serum Hcy, GAL3 and MCP-1 in patients with acute ischemic stroke are highly expressed, and their levels are closely related to the degree of disease, cerebral infarction area and prognosis. The combined detection of Hcy, GAL3 and MCP-1 could improve the accuracy and sensitivity of diagnosis, and could be used as an effective index for clinical diagnosis, condition and prognosis evaluation of acute ischemic stroke. Key words: Brain ischemia; Stroke; Homocysteine; Galectin 3; Chemokine CCL2